Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Werewolf Therapeutics (HOWL) Income from Continuing Operations (2021 - 2025)

Werewolf Therapeutics (HOWL) has disclosed Income from Continuing Operations for 5 consecutive years, with 10223000.0 as the latest value for Q4 2025.

  • Quarterly Income from Continuing Operations rose 49.66% to 10223000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 62843000.0 through Dec 2025, up 12.2% year-over-year, with the annual reading at 62843000.0 for FY2025, 12.2% up from the prior year.
  • Income from Continuing Operations for Q4 2025 was 10223000.0 at Werewolf Therapeutics, up from 16370000.0 in the prior quarter.
  • The five-year high for Income from Continuing Operations was 5073000.0 in Q2 2023, with the low at 20306000.0 in Q4 2024.
  • Average Income from Continuing Operations over 5 years is 13739650.0, with a median of 14308000.0 recorded in 2021.
  • The sharpest move saw Income from Continuing Operations skyrocketed 65.9% in 2023, then plummeted 260.91% in 2024.
  • Over 5 years, Income from Continuing Operations stood at 17918000.0 in 2021, then surged by 33.03% to 12000000.0 in 2022, then increased by 0.02% to 11997000.0 in 2023, then tumbled by 69.26% to 20306000.0 in 2024, then soared by 49.66% to 10223000.0 in 2025.
  • According to Business Quant data, Income from Continuing Operations over the past three periods came in at 10223000.0, 16370000.0, and 17993000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.